STRS Ohio’s OnKure Therapeutics OKUR Stock Holding History

STRS Ohio’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-150	Closed	-$4K	–	2333
2022 Q1	$4K	Hold	150	–	–	﹤0.01%	2119
2021 Q4	$12K	Hold	150	–	–	﹤0.01%	2147
2021 Q3	$11K	Hold	150	–	–	﹤0.01%	2204
2021 Q2	$13K	Buy	+150	New	+$16.7K	﹤0.01%	2193

Other funds holding OKUR

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

RVM

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

STRS Ohio's OKUR Position: Q2 2022 in Review

STRS Ohio sold out of OnKure Therapeutics (OKUR) in Q2 2022, closing a stake of 150 shares — an estimated $4K sold.

STRS Ohio first reported a position in OKUR in Q2 2021 and held it in 4 quarters. The position peaked at $13K in Q2 2021. 33 funds tracked by Wall St. Rank hold OKUR as of Q2 2022.

STRS Ohio reported no remaining OnKure Therapeutics position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 150 OnKure Therapeutics shares in Q2 2022, an estimated $4K.
STRS Ohio first reported a position in OnKure Therapeutics in Q2 2021 and held it in 4 quarters.
STRS Ohio's OnKure Therapeutics position peaked at $13K in Q2 2021.
33 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.